BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
BridgeBio Pharma is seeking a Biostatistician to contribute to medical affairs activities in the development of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) therapies. The role involves statistical analysis, scientific writing, and collaborating with internal and external teams to ensure high-quality outputs. The position also involves ensuring accurate and timely deliverables to ensure successful outcomes in trials and regulatory submissions.
BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
Revolution Medicines